Insider Transactions in Q3 2022 at Bei Gene, Ltd. (BGNE)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 21
2022
|
John Oyler Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
19,480
-53.23%
|
$2,922,000
$150.74 P/Share
|
|
Sep 20
2022
|
John Oyler Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
30,520
-87.36%
|
$4,669,560
$153.97 P/Share
|
|
Sep 06
2022
|
Xiaodong Wang Director |
SELL
Bona fide gift
|
Direct |
33,410
-0.59%
|
-
|
|
Aug 22
2022
|
Qingqing Yi Director |
SELL
Other acquisition or disposition
|
Direct |
7,800
-31.85%
|
-
|
|
Aug 22
2022
|
Hhlr Advisors, Ltd. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
7,800
+0.01%
|
-
|
|
Aug 08
2022
|
Xiaodong Wang Director |
SELL
Open market or private sale
|
Direct |
6,060
-61.47%
|
$1,224,120
$202.11 P/Share
|
|
Aug 05
2022
|
Xiaodong Wang Director |
SELL
Open market or private sale
|
Direct |
5,000
-36.33%
|
$965,000
$193.29 P/Share
|
|
Aug 05
2022
|
Xiaodong Wang Director |
SELL
Open market or private sale
|
Indirect |
5,000
-37.0%
|
$965,000
$193.41 P/Share
|
|
Jul 01
2022
|
Julia Aijun Wang Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
295
-100.0%
|
$46,610
$158.5 P/Share
|